West Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by Groupama Asset Managment

Groupama Asset Managment raised its position in shares of West Pharmaceutical Services, Inc. (NYSE:WSTFree Report) by 342.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,308 shares of the medical instruments supplier’s stock after purchasing an additional 1,786 shares during the period. Groupama Asset Managment’s holdings in West Pharmaceutical Services were worth $693,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of WST. Crewe Advisors LLC raised its holdings in shares of West Pharmaceutical Services by 322.7% during the second quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 71 shares during the last quarter. Northwest Investment Counselors LLC acquired a new stake in West Pharmaceutical Services in the 3rd quarter valued at approximately $30,000. Brooklyn Investment Group bought a new stake in West Pharmaceutical Services during the 3rd quarter valued at $41,000. Quest Partners LLC boosted its position in West Pharmaceutical Services by 5,633.3% during the 2nd quarter. Quest Partners LLC now owns 172 shares of the medical instruments supplier’s stock worth $57,000 after acquiring an additional 169 shares during the period. Finally, Blue Trust Inc. grew its stake in shares of West Pharmaceutical Services by 332.1% in the second quarter. Blue Trust Inc. now owns 242 shares of the medical instruments supplier’s stock worth $80,000 after purchasing an additional 186 shares in the last quarter. Institutional investors own 93.90% of the company’s stock.

Insider Activity

In other news, VP Charles Witherspoon sold 703 shares of the firm’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total transaction of $218,211.20. Following the completion of the transaction, the vice president now owns 1,253 shares in the company, valued at approximately $388,931.20. This trade represents a 35.94 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.53% of the stock is owned by insiders.

West Pharmaceutical Services Price Performance

Shares of WST opened at $322.16 on Tuesday. The firm has a market capitalization of $23.33 billion, a price-to-earnings ratio of 47.80, a price-to-earnings-growth ratio of 24.47 and a beta of 1.01. The stock’s fifty day moving average is $310.61 and its 200-day moving average is $311.75. West Pharmaceutical Services, Inc. has a one year low of $265.00 and a one year high of $413.70. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.23 and a current ratio of 3.00.

West Pharmaceutical Services (NYSE:WSTGet Free Report) last released its earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 EPS for the quarter, beating the consensus estimate of $1.50 by $0.35. The firm had revenue of $746.90 million for the quarter, compared to analysts’ expectations of $709.62 million. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. West Pharmaceutical Services’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter last year, the company earned $2.16 EPS. Equities analysts anticipate that West Pharmaceutical Services, Inc. will post 6.64 EPS for the current year.

West Pharmaceutical Services Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, November 20th. Shareholders of record on Wednesday, November 13th were paid a dividend of $0.21 per share. This is a positive change from West Pharmaceutical Services’s previous quarterly dividend of $0.20. This represents a $0.84 dividend on an annualized basis and a yield of 0.26%. The ex-dividend date was Wednesday, November 13th. West Pharmaceutical Services’s dividend payout ratio (DPR) is presently 12.46%.

West Pharmaceutical Services Profile

(Free Report)

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

Featured Articles

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WSTFree Report).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.